Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin prophylaxis after allogeneic SCT
NCT00215007Phase 3Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in bacterial infection, sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00215007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215007.